Summary & Overview
CPT 83521: Free Serum Immunoglobulin Light Chain Assay
CPT code 83521 denotes a laboratory chemistry test that measures concentrations of free immunoglobulin light chains — kappa or lambda — in serum. These quantitative assays, often performed by turbidimetric methods, are clinically important for diagnosing and monitoring plasma‑cell disorders such as multiple myeloma and primary amyloidosis. Nationally, use of measurements for free light chains supports disease detection, therapeutic monitoring, and progression assessment across inpatient and outpatient laboratory settings.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication summarizes payer coverage patterns and benchmarking considerations, highlights relevant clinical context for test utilization, and outlines common service settings where the test is performed. Readers will find concise benchmarks for utilization and reimbursement patterns, an overview of clinical indications and testing methods, and notes on reporting and coding practice relevant to laboratory administrators and billing staff. Data not available in the input is indicated where applicable.
Billing Code Overview
CPT code 83521 describes a laboratory chemistry procedure in which a lab analyst measures the concentration of each immunoglobulin light chain, kappa or lambda, in a serum specimen. The assay quantifies free (unbound) kappa and lambda light chains, commonly using methods such as turbidimetry, which assesses light absorption by suspended particles to determine analyte levels.
Service Type: Laboratory diagnostic chemistry test
Typical Site of Service: Clinical laboratory or hospital laboratory; outpatient phlebotomy/collection sites
Clinical context: Measurements of free serum kappa and lambda light chains assist clinicians in the diagnosis and monitoring of plasma‑cell disorders, including multiple myeloma and primary (AL) amyloidosis.
Clinical & Coding Specifications
Clinical Context
A 66-year-old patient with progressive fatigue, unexplained anemia, and persistent back pain is referred to hematology for evaluation of a suspected plasma cell disorder. The clinician orders serum free light chain testing to measure free kappa and lambda immunoglobulin light chains. Blood is drawn in an outpatient phlebotomy clinic or hospital laboratory; the serum specimen is processed by the clinical laboratory using turbidimetry or another validated chemistry method. The lab analyst runs 83521 to quantify each free light chain (kappa or lambda) level. Results are reported to the ordering provider and used alongside serum protein electrophoresis, immunofixation, and clinical findings to help diagnose or monitor multiple myeloma, primary amyloidosis, or light chain disease. Typical sites of service include outpatient laboratory, hospital laboratory, and ambulatory infusion centers where monitoring of plasma cell disorder therapy occurs.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the professional interpretation component, if applicable in split-billing arrangements for specialized lab analysis. |
TC |